A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus.
Cyclic acyldepsipeptides (ADEPs) are a novel class of antibacterial agents, some of which (e.g., ADEP 4) are highly active against Gram-positive bacteria. The focus of these in vivo studies is ADEP B315, a rationally designed compound that has the most potent in vitro activity of any ADEP analog rep...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4839560?pdf=render |
id |
doaj-18ad74b3db3546f6a56a4490daeb051a |
---|---|
record_format |
Article |
spelling |
doaj-18ad74b3db3546f6a56a4490daeb051a2020-11-24T22:21:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01114e015391210.1371/journal.pone.0153912A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus.Marios ArvanitisGang LiDe-Dong LiDaniel CotnoirLisa Ganley-LealDaniel W CarneyJason K SelloEleftherios MylonakisCyclic acyldepsipeptides (ADEPs) are a novel class of antibacterial agents, some of which (e.g., ADEP 4) are highly active against Gram-positive bacteria. The focus of these in vivo studies is ADEP B315, a rationally designed compound that has the most potent in vitro activity of any ADEP analog reported to date.In vivo efficacy experiments were performed using lethal intraperitoneal mice infection models with a methicillin-sensitive S. aureus (MSSA) and a methicillin-resistant (MRSA) strain. The infected mice were treated with ADEP B315, a des-methyl analog of ADEP 4, vancomycin, or the vehicle used for the ADEPs and their survival was assessed daily. A subset of MSSA-infected mice was sacrificed soon after inoculation and the bacterial burden was measured in their livers and spleens. The toxicity of ADEP B315 was assessed in viability assays using human whole blood cultures.In the MSSA experiments, all mice treated with the vehicle succumbed to the infection within 24 hours. All tested compounds were effective in prolonging survival of infected mice (p<0.001). Mice treated with ADEP B315 had a 39% survival rate by 10 days compared to 7% survival in mice treated with a des-methyl ADEP 4 analog (p = 0.017). Survival of the infected mice treated with ADEP B315 was comparable to those treated with vanocmycin (p = 0.12) at the same dose. Further, bacterial burden in the liver and spleen was significantly lower in mice treated with ADEP B315 compared to controls. In the MRSA experiments, ADEP B315 was able to significantly prolong survival compared to mice treated with either the vehicle (p = 0.001) or vancomycin (p = 0.007). ADEP B315 exhibited no significant toxicity in human whole blood cultures at concentrations up to 25 μg/ml.ADEP B315 is safe and can cure mice that have lethal infections of methicillin-sensitive and -resistant strains of S. aureus.http://europepmc.org/articles/PMC4839560?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marios Arvanitis Gang Li De-Dong Li Daniel Cotnoir Lisa Ganley-Leal Daniel W Carney Jason K Sello Eleftherios Mylonakis |
spellingShingle |
Marios Arvanitis Gang Li De-Dong Li Daniel Cotnoir Lisa Ganley-Leal Daniel W Carney Jason K Sello Eleftherios Mylonakis A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. PLoS ONE |
author_facet |
Marios Arvanitis Gang Li De-Dong Li Daniel Cotnoir Lisa Ganley-Leal Daniel W Carney Jason K Sello Eleftherios Mylonakis |
author_sort |
Marios Arvanitis |
title |
A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. |
title_short |
A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. |
title_full |
A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. |
title_fullStr |
A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. |
title_full_unstemmed |
A Conformationally Constrained Cyclic Acyldepsipeptide Is Highly Effective in Mice Infected with Methicillin-Susceptible and -Resistant Staphylococcus aureus. |
title_sort |
conformationally constrained cyclic acyldepsipeptide is highly effective in mice infected with methicillin-susceptible and -resistant staphylococcus aureus. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
Cyclic acyldepsipeptides (ADEPs) are a novel class of antibacterial agents, some of which (e.g., ADEP 4) are highly active against Gram-positive bacteria. The focus of these in vivo studies is ADEP B315, a rationally designed compound that has the most potent in vitro activity of any ADEP analog reported to date.In vivo efficacy experiments were performed using lethal intraperitoneal mice infection models with a methicillin-sensitive S. aureus (MSSA) and a methicillin-resistant (MRSA) strain. The infected mice were treated with ADEP B315, a des-methyl analog of ADEP 4, vancomycin, or the vehicle used for the ADEPs and their survival was assessed daily. A subset of MSSA-infected mice was sacrificed soon after inoculation and the bacterial burden was measured in their livers and spleens. The toxicity of ADEP B315 was assessed in viability assays using human whole blood cultures.In the MSSA experiments, all mice treated with the vehicle succumbed to the infection within 24 hours. All tested compounds were effective in prolonging survival of infected mice (p<0.001). Mice treated with ADEP B315 had a 39% survival rate by 10 days compared to 7% survival in mice treated with a des-methyl ADEP 4 analog (p = 0.017). Survival of the infected mice treated with ADEP B315 was comparable to those treated with vanocmycin (p = 0.12) at the same dose. Further, bacterial burden in the liver and spleen was significantly lower in mice treated with ADEP B315 compared to controls. In the MRSA experiments, ADEP B315 was able to significantly prolong survival compared to mice treated with either the vehicle (p = 0.001) or vancomycin (p = 0.007). ADEP B315 exhibited no significant toxicity in human whole blood cultures at concentrations up to 25 μg/ml.ADEP B315 is safe and can cure mice that have lethal infections of methicillin-sensitive and -resistant strains of S. aureus. |
url |
http://europepmc.org/articles/PMC4839560?pdf=render |
work_keys_str_mv |
AT mariosarvanitis aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT gangli aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT dedongli aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT danielcotnoir aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT lisaganleyleal aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT danielwcarney aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT jasonksello aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT eleftheriosmylonakis aconformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT mariosarvanitis conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT gangli conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT dedongli conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT danielcotnoir conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT lisaganleyleal conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT danielwcarney conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT jasonksello conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus AT eleftheriosmylonakis conformationallyconstrainedcyclicacyldepsipeptideishighlyeffectiveinmiceinfectedwithmethicillinsusceptibleandresistantstaphylococcusaureus |
_version_ |
1725770575962439680 |